Mirae Asset Global Etfs Holdings Ltd. Century Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 11,389 shares of IPSC stock, worth $18,791. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,389Holding current value
$18,791% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IPSC
# of Institutions
61Shares Held
35MCall Options Held
7KPut Options Held
300-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$8.93 Million2.82% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$8.89 Million1.51% of portfolio
-
Boxer Capital, LLC San Diego, CA4.9MShares$8.09 Million0.69% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$5.29 Million0.71% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$4.78 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $97.2M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...